Credit Suisse Ag Cytosorbents Corp Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.22 $38 - $70	22 New	22 $0
Q1 2021 May 14, 2021	SELL	$8.23 - $11.48 $97,048 - $135,372	-11,792 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$7.65 - $8.98 $90,208 - $105,892	11,792 New	11,792 $94,000
Q4 2019 Feb 12, 2020	SELL	$3.61 - $5.22 $38,338 - $55,436	-10,620 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$4.33 - $7.63 $22,217 - $39,149	-5,131 Reduced 32.58%	10,620 $53,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $93,245 - $122,542	15,751 New	15,751 $104,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $12.35 $95,689 - $171,269	-13,868 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$6.55 - $8.2 $67,334 - $84,295	-10,280 Reduced 42.57%	13,868 $98,000
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $142,473 - $170,243	24,148	24,148 $157,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $43.1M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.